Inpatient resource use and costs associated with switching from oral antipsychotics to aripiprazole once-monthly for the treatment of schizophrenia

BACKGROUND: Schizophrenia is associated with high direct healthcare costs due to progression of disease and frequent occurrence of relapses. Aripiprazole once-monthly (AOM) has been shown to reduce total psychiatric hospitalizations among patients who switched from oral standard of care (SOC) therap...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Michele, Gutierrez, Benjamin, Offord, Steve J., Blanchette, Christopher M., Eramo, Anna, Earnshaw, Stephanie, Kamat, Siddhesh A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Just Medical Media Limited 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831639/
https://www.ncbi.nlm.nih.gov/pubmed/27114739
http://dx.doi.org/10.7573/dic.212273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831639/
https://www.ncbi.nlm.nih.gov/pubmed/27114739
http://dx.doi.org/10.7573/dic.212273

Ejemplares similares